Abstract:Objective To investigate the expression of SCL/TAL1 interrupting locus (STIL) protein in elderly patients with cervical cancer and its relationship with prognosis. Methods A total of 97 elderly patients with cervical cancer in the Hospital Affiliated to Xuzhou Medical University from January 2019 to January 2023 were selected as the cervical cancer group, 80 elderly patients with cervical intraepithelial neoplasia (CIN) as the CIN group, and 80 elderly patients with chronic cervicitis as the chronic cervicitis group. STIL protein expression and high-risk human papilloma virus (HPV) infection status in lesion tissues were measured and compared among the three groups. Spearman correlation analysis was used to analyze the relationship between STIL protein expression and high-risk HPV infection in cervical cancer tissues. Follow-up was performed until June 2024, and the survival curves were plotted to analyze the survival status of cervical cancer patients with different STIL protein expressions. Cox proportional hazards regression was employed to identify factors affecting the prognosis of elderly patients with cervical cancer. SPSS 26.0 was used for statistical analysis. Data comparison between groups was performed using t test or χ2 test depending on data type. Results The high expression rate of STIL and high-risk HPV infection rate in cervical cancer group were higher than those in the CIN group and the chronic cervicitis group; STIL high expression rate and high-risk HPV infection rate in CIN Ⅱ-Ⅲ patients were higher than those in CIN Ⅰ patients; the high expression rate of STIL in cervical cancer tissues was higher than that in adjacent tissues; and the differences were all statistically significant (P<0.05). Spearman correlation analysis showed a positive correlation between STIL high expression rate and high-risk HPV infection in cervical cancer patients (rs=0.409; P<0.001). The high expression rate of STIL in cervical cancer tissues of low differentiation was higher than that with middle-to-high differentiation; the high expression rate of STIL with FIGO stage Ⅲ-Ⅳ was higher than that with FIGO stage Ⅰ-Ⅱ; the high expression rate of STIL in patients with vascular invasion was higher than that in those without vascular invasion; and the differences were all statistically significant (P<0.05). There were no statistical differences in STIL expression among the other clinicopathological data groups (age, histological type, lymph node metastasis, and tumor diameter) (P>0.05). Postoperative follow-up lasted 4-66 months, with an average of 45.48 months. The plotted survival curve indicated that the patients with high STLI expression had a lower survival rate than those with low STLI expression, and the differences were all statistically significant (Log rankχ2=3.935, P=0.045). Cox multivariate regression analysis suggested that high expression of STIL (HR=1.853,95%CI 1.118-3.073), vascular cancer thrombus (HR=1.645,95%CI 1.116-2.426), and FIGO stage Ⅲ-Ⅳ (HR=1.680,95%CI 1.165-2.424) were independent risk factors for the prognosis in elderly patients with cervical cancer (P<0.05). Conclusion STIL is highly expressed in cervical cancer tissues and is related to high-risk HPV infection. High expression of STIL can be used as a predictor of poor prognosis in these patients.